Emboline
Developed the only embolic protection device designed to provide complete protection of the brain and other critical organs by capturing and removing emboli produced during the procedure.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD340—510m (Dealroom.co estimates May 2021.)
Santa Cruz California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$10.0m | Series B | ||
* | N/A | $5.0m Valuation: $50.0m | Late VC |
| N/A | $10.0m | Series C | |
$55.0m | Series D | ||
| Total Funding | AUD124m | ||
Recent News about Emboline
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.